Identification of highrisk factors as indicators for adjuvant therapy in stage II colon cancer patients treated at a single institution

Author：        

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.6, Iss.3, 2013-01, pp. : 659-666

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Surgeon and Adjuvant Therapy for Stage II Colon Cancer

By Ota David   Nelson Heidi  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 272-273

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant therapy in patients with stage II and III colon cancer under 70 years of age

By Dumont Sarah N   Chibaudel Benoist   Bengrine-Lefèvre Leïla   André Thierry   de Gramont Aimery  

Colorectal Cancer, Vol. 2, Iss. 3, 2013-06 ,pp. : 205-217

Future Medicine

Access to resources Recommend Favorite

Capecitabine: As Adjuvant Therapy in Stage III Colon Cancer

By Robins Gayle W.   Keating Gillian M.  

American Journal of Cancer, Vol. 4, Iss. 5, 2005-01 ,pp. : 315-323

Adis International

Access to resources Recommend Favorite

Identification of a High-Risk Subgroup of Patients with Resected pT3 Oral Cavity Cancer in Need of Postoperative Adjuvant Therapy

By Liao Chun-Ta  

Annals of Surgical Oncology, Vol. 18, Iss. 9, 2011-09 ,pp. : 2569-2578

Springer Publishing Company

Access to resources Recommend Favorite

Practical Outcome of Adjuvant FOLFOX4 Chemotherapy in Elderly Patients with Stage III Colon Cancer: Single-center Study in Korea

By Kim Ji-Yeon   Kim Yu Jung   Lee Keun-Wook   Lee Jong Seok   Kim Duck-Woo   Kang Sung-Bum   Lee Hye Seung   Jang Na Young   Kim Jae-Sung   Kim Jee Hyun  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 2, 2013-02 ,pp. : 132-138

Oxford University Press

Access to resources Recommend Favorite